Related Experiment Video
Updated: Jun 30, 2025

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
Dotinurad restores exacerbated kidney dysfunction in hyperuricemic patients with chronic kidney disease
Hoichi Amano1, Seiji Kobayashi1, Hiroyuki Terawaki2,3
1Department of Nephrology, Teikyo University Chiba Medical Center, Chiba, Japan.
Dotinurad treatment improved kidney function in patients with chronic kidney disease and hyperuricemia. This urate-lowering therapy showed potential in preventing further renal decline.
Area of Science:
- Nephrology
- Pharmacology
Background:
- Chronic kidney disease (CKD) and hyperuricemia (HUA) are common conditions.
- Elevated serum urate levels (sUA) can negatively impact renal function.
Purpose of the Study:
- To evaluate the efficacy of dotinurad, a novel urate-lowering agent, in improving renal function in CKD patients with HUA.
Main Methods:
- A study involving 35 CKD patients with HUA.
- Patients underwent a 3-month observation period followed by 3 months of dotinurad treatment.
- Changes in estimated glomerular filtration rate (eGFR) and sUA levels were monitored.
Main Results:
- During observation, eGFR significantly declined.
- Dotinurad treatment led to eGFR recovery (from 31.8 to 36.5 mL/min/1.73 m²) and decreased sUA (from 8.1 to 6.7 mg/dL).
- Increased eGFR was correlated with decreased sUA (R=0.375, p=0.0263).
Conclusions:
- Dotinurad administration appears beneficial for restoring kidney function in CKD patients with HUA.
- Dotinurad shows potential as a therapeutic option for preventing HUA-induced kidney function decline.
More Related Videos
11:47Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Antihypertensive Drugs: Action of Diuretics
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Heart Failure Drugs: Diuretics
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
Dipeptidyl Peptidase 4 Inhibitors